期刊文献+

喉癌组织及手术切缘P53和P16蛋白表达与局部复发的关系 被引量:3

The status of protein P16 and P53 in the surgical margins of laryngeal carcinoma and the association with local recurrence
下载PDF
导出
摘要 目的 用免疫组织化学方法监测P16和P5 3蛋白在喉癌手术切缘中的表达情况及其与肿瘤局部复发的关系。方法 选择HE染色病理学检查手术切缘为阴性但术后肿瘤局部复发的 5 2例喉癌作为复发组 ,并按照患者的年龄、性别、临床分型、TNM分期、病理分级、术前放疗剂量等可能影响因素选择 48例随访 5年以上无肿瘤局部复发者为无复发组。对 2组手术切缘和肿瘤标本同时行P16和P5 3蛋白免疫组织化学检查。结果 在 10 0例喉癌组织中P5 3蛋白的表达率和P16蛋白的丢失率分别为 5 4%和 40 % ,喉癌组织中P16和P5 3蛋白表达同时异常的喉癌患者当其手术切缘粘膜中P16和P5 3蛋白表达也同时异常时 ,其术后肿瘤局部复发率为 85 %。P16和P5 3蛋白表达与喉癌的临床分型和T分期无关。结论 采用免疫组化方法联合检测P16和P5 3蛋白在喉癌组织和手术切缘中的表达情况可为筛选术后肿瘤局部复发的高危病例提供依据。 Objective To assess the status of P53 and P16 of surgical margins in laryngeal carcinoma and the association with the local recurrence following surgical treatment Methods The status of P53 and P16 of surgical margins in laryngeal carcinoma was studied using immunohistochemistry (IHC) staining method in 100 cases of laryngeal carcinoma. Fifty-two of them had recurrent tumors while 48 cases were free of local recurrence after 5-year follow up. The original tumor sites and T stages, which bear important influence over the risk of local recurrence, were strictly matched between the two groups, and the ages and preoperative doses of radiation were also considered. Results The percentage of local recurrence was 85% in these patients who showed positive staining for P53 and simultaneous negative staining for P16 in both the cancer tissues and the surgical margins. No association was found between the expression of P53 and P16 and the clinical types or T stages. Conclusion The status of P53 and P16 in combination demonstrated by IHC technique in surgical margins of laryngeal carcinoma may predict the possibility of local recurrence.
出处 《中华耳鼻咽喉科杂志》 CSCD 2000年第6期461-463,共3页 Chinese Journal of Otorhinolaryngology
关键词 喉肿瘤 蛋白质P53 蛋白质P16 肿瘤复发 局部 Laryngeal neoplasms Protein P53 Protein P16 Neoplasms recurrence,local
  • 相关文献

参考文献7

  • 1Lane DP.guardian of the genome[].Nature.1992
  • 2Nigro JM,Baker SJ,Preisinger AC.Mutations in the P53 gene occur in diverse human tumor types[].Nature.1989
  • 3Maestro R,Doleetti R,Gasprotto D,et al.High frequency of P53 gene alterations associated with protein overeypresion in human squamous cell carcinoma of the larynx[].Oncegene.1992
  • 4Boyle J O,John H,Koch W.The incidence of p53 mutations increases with progression of head and neck cancer[].Cancer Research.1993
  • 5Califano J.Genetic progression model for head and neck cancer:implications for field cancerization[].Cancer Research.1996
  • 6Nowell PC.The clonal evolution of tumor cell populations[].Science.1979
  • 7G allo O,Santucci M,Franchi A.Cumulative prognostic value of P16 /CDKN2 and p53 oncoprotein expression in premalignant laryngeal lesions[].Journal of the National Cancer Institute.1997

同被引文献36

  • 1王伟,尹家俊,路小光,姜志良,姚永强,赵晖.MMP-2和CD44v6蛋白表达与胃癌生物学行为相关性的实验研究[J].中国肿瘤临床与康复,2005,12(6):502-506. 被引量:5
  • 2Jacobs JR, Ahmed K, Casiano R, et al. Implications of postitive surgical margins. Laryngoscope, 1993,13:64 : 68.
  • 3Margaret Brandwein, David Yong Zhang. Molecular Margins: A Better Measure? Arch Otolaryngol Head Neck Surg, 1998,124 : 841 - 842.
  • 4Greenblatt MS, Bennett WP, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis [J].Cancer Res1994, 54 (18) :4855-78.
  • 5Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck. N Eng J Med,1995,332 (7) :429-453.
  • 6Huang X, Pateromichelakis S, Hills A, et al. p53 Mutations in deep tissues are more strongly associated with recurrence than mutation- positive mucosal margins[J]. Clin Cancer Res, 2007, 13 (20):609926106.
  • 7Allegra E, Puzzo L, Cutrona D, et al. p53 overexpression on the resection margins as a marker of local recurrence in glottic Tla carcinoma. Acta Otorhinolaryngol Ital. 2003 Deck23 (6) :454-8.
  • 8Sorrells DL Jr, Ghali GE, De Benedetti. A, et al. Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers. J Oral Maxillofac Surg. 1999 Mar;57 (3):294-9.
  • 9Haydon MS, Googe JD, Sorrells DS, et al. Progression of eIF4e gene amplification and overexpression in benign and malignant tumors of the head and neck, Cancer. 2000 Jun 15, 88(12):2803-10.
  • 10Chandy B, Ahreo F, Nassar R, et al. Expression of the proto-oncogene eIF4E in inflammation of the oral cavity. Otolaryngol Head Neck Surg, 2002 Marl 126 (3) :290-5.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部